(Q39623814)

English

Antitumor activity of BIBF 1120, a triple angiokinase inhibitor, and use of VEGFR2+pTyr+ peripheral blood leukocytes as a pharmacodynamic biomarker in vivo

scientific article published on 3 December 2010

In more languages
default values for all languages
No label defined

No description defined

Statements

Antitumor activity of BIBF 1120, a triple angiokinase inhibitor, and use of VEGFR2+pTyr+ peripheral blood leukocytes as a pharmacodynamic biomarker in vivo (English)
0 references
0 references
Kazuyuki Furuta
Hiroyasu Kaneda
Kazuko Matsumoto
Keiichi Aomatsu
Yoshihiko Fujita
Nagahiro Saijo

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit